We strategically use our resources to support and advance a range of vaccine approaches that target both humoral and cellular immunity. 

MVI maintains a diverse portfolio of preclinical, early clinical, and advanced clinical projects. We test multiple vaccine candidates simultaneously. Find out more about feasibility studies, translational projects, and vaccine candidates by clicking on the respective links.